Literature DB >> 7762918

Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.

.   

Abstract

Mesh:

Year:  1995        PMID: 7762918     DOI: 10.7326/0003-4819-123-1-199507010-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  51 in total

Review 1.  Economic notes. Discounting.

Authors:  D J Torgerson; J Raftery
Journal:  BMJ       Date:  1999-10-02

Review 2.  Design, analysis and presentation of multinational economic studies: the need for guidance.

Authors:  Francis Pang
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Conflict of interest in industry-sponsored economic evaluations: real or imagined?

Authors:  M Barbieri; M F Drummond
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

4.  Economic analysis of randomized, controlled trials.

Authors:  G H Lyman
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 5.  Modelling in health economic evaluation. What is its place? What is its value?

Authors:  A Brennan; R Akehurst
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

6.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

7.  Measuring sensitivity in pharmacoeconomic studies. An integration of point-sensitivity and range-sensitivity.

Authors:  M J Nuijten; M Hardens
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

Review 8.  The costs of epilepsy and cost-based evaluations of anticonvulsants.

Authors:  W G Johnson
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

9.  Applied pharmacoeconomics. When can publication be legitimately withheld?

Authors:  G C Yee; A L Hillman
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

Review 10.  Why training is the key to successful guideline implementation.

Authors:  A D Paltiel; P J Neumann
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.